Available from: Jett, L., Lger, R., Thibaudeau, K., Benquet, C., Robitaille, M., Pellerin, I., Paradis, V., van Wyk, P., Pham, K., & Bridon, D
Important safety information: These medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells
Unlike traditional oral supplements that rely on the digestive system, PatchMDs transdermal patches deliver nutrients directly through the skin, avoiding potential gastrointestinal discomfort and absorption issues
nasal gels and sprays